S&P Global Ratings' senior pharma analyst, Ji Liu, discusses the puts and takes for our new Regeneron Pharmaceuticals ratings.
The S&P Pharma Dose - Episode 35 - Regeneron Pharmaceuticals: Steady Growth vs. Heavy Product Concentration
Instant Insights: Key Takeaways From Our Research
U.S. Oil And Gas: Oil Price Drops Could Bore Into Producer Spending
Cracks In Consumer Confidence Amid Tariffs And Inflation Could Lead To Tighter U.S. Leisure Spending
Pre-Tariff U.S. Middle-Market Collateralized Loan Obligation Rally Is Unlikely To Last
S&P Global Ratings' senior pharma analyst, Ji Liu, discusses the puts and takes for our new Regeneron Pharmaceuticals ratings.